CYTO - Altamira Therapeutics Ltd
IEX Last Trade
0.89
-0.025 -2.798%
Share volume: 36,939
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$0.91
-0.02
-2.72%
View ratios
| Fiscal Date | |
|---|---|
| Fiscal Quarter | |
| Report Date | |
| Assets | |
| Total Assets | |
| Current Assets | |
| Inventories | |
| Other Current Assets | |
| Short Term Investments | |
| Total Receivables | |
| Current Cash | |
| Total Non-current Assets | |
| Property Plant Equipment | |
| Other Assets | |
| Intangible Assets | |
| Goodwill | |
| Liabilities and shareholders’ equity | |
| Total Liabilities and shareholders’ equity | |
| Total liabilities | |
| Total current liabilities | |
| Accounts Payable | |
| Other liabilities | |
| Current long term debt | |
| Long term debt | |
| Other liabilities | |
| Minority interest | |
| Total Shareholder equity | |
| Common stock | |
| Retained earnings |